A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer

PHASE3TerminatedINTERVENTIONAL

Enrollment

214

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

July 31, 2010

Study Completion Date

November 30, 2010

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

CBT-1

(50 mg caps) 500 mg/m2/day x 7 + paclitaxel 135 mg/m2 + carboplatin AUC 6

OTHER

Placebo

(50 mg caps) 500 mg/m2/day x 7 + paclitaxel 135 mg/m2 + carboplatin AUC 6

Trial Locations (1)

Arizona Clinical Research Center, Tuscon